03.30.19

The UK Supreme Court’s Latest Decision is Ammunition for the FCC to Scuttle the Unified Patent Court Agreement (UPCA)

Posted in Courtroom, Europe, Patents at 9:33 am by Dr. Roy Schestowitz

Team UPC is, understandably, going bonkers (feeling unlucky in the face of justice)

A black cat

Summary: The quality of European Patents is appalling enough that no courts would entrust EPO people with something like the Unified Patent Court (UPC); The UK Supreme Court has proven this point yet again and we suppose that the German Constitutional Court (FCC) pays close attention not only to dirty tactics from Team UPC (trying to trick the court into premature decisions, based on fabrications)

THE European Patent Office (EPO) suffered a blow some days ago because its impotent patent on impotence treatment was smashed to pieces at one of Europe’s most respected courts, the UK Supreme Court.

“They’re both spoiled brats of UPC, who on behalf of large (and international/foreign) pharmaceutical giants try to pass the UPC (ratify UPCA).”Marks & Clerk’s Mike Gilbert and Jonathan Stafford wrote about it before the weekend, as did the liars and crooks from Bristows LLP. They’re both spoiled brats of UPC, who on behalf of large (and international/foreign) pharmaceutical giants try to pass the UPC (ratify UPCA). We’ll say more about that in a moment.

Here is what patent maximalists at Managing IP [sic] wrote about it:

The UK’s highest court yesterday affirmed that a patent licensed from former biotech company Icos to Eli Lilly for the erectile dysfunction (ED) drug Cialis (tadalafil) is invalid.

A couple of new comments have also just appeared at IP Kat [1, 2], another site of patent maximalists. It’s about the highest British court finding that EPO granted this bogus patent. “Here is how there is a “reasonable expectation of success”,” said the first of those two comments. “When you follow the reasoning, the court decided that when carrying out trials of the drug the skilled person would have investigated the effect of 25mg, 50mg, and 100mg doses. Doing this they would have inevitably found the dosage plateau. They don’t need to have expected to find the plateau or have a reasonable expectation they would find it, it was an inevitability that they would find it just by carrying out the routine trials of the drug. Having found the dosage plateau that extends over the 25mg to 100mg range there is then a reasonable expectation that the lower end of the dosage plateau might extend down to 5mg.”

Notice that the so-called ‘innovation’ is to do with dosages. The comment continued: “There is no hindsight in this assessment just a reasonable assessment of how the trials of this, or any other, new drug would have been carried out at the priority date of the patent. Essentially, the dosing patent is just the Applicant applying to protect the inevitable outcome of the clinical trials of the drug because it is different from what was envisaged in the original patent. There is no inventive step.

Why was it even considered patent-eligible? Imagine if something like UPC was tasked or assigned to rule on this…

The second comment said: “I perfectly understand this line of reasoning, but I still can hardly adhere to it. The criterion of “reasonable expectation of success” says what it says: was it expectable for the skilled person to find the identified effect at the time of filing ?”

Why is this even considered an invention? It’s more like a recipe? Are cooking recipes next in line? We gave examples to that effect a few days ago.

“Importing the research process into that reasoning is no longer inventive step, because otherwise only new research processes could remain patentable, any finding based on known research processes would simply be obvious to try, whatever the efforts.”
      –Anonymous
“Research,” the comment continued, “even being made in clinical trials, remains research, i.e. exploration of the yet unidentified (and unsuggested for inventive step). If the prior art would have suggested that this drug would be active at low doses, I would then have agreed that a motivation would exist to specifically look for the lower dosages. However, even though this exploration was made in standardized clinical trials, this remained research and exploration. Moreover, the inventors have no choice but to carry out this research in clinical trials because it is performed on humans. If the product would not have been a drug, hence would not have required clinical trials, the same dose-effect experiments would have been performed to find out what doses are the most efficient. And, if I follow properly the court’s reasoning (and yours), it could then have been considered inventive because there would have been no clue how the inventors had come to this finding in theri research process.
For all types of inventions, the more so for inventions in the life science field in which the “resonable expectation of success” principle has been developped, my view is always the same, inventive step does not have to be assessed based on the process how to come to a certain finding, i.e. the invention, but only on the facts available, in particular what the prior art is teaching and what level of skill does the skilled person have. Importing the research process into that reasoning is no longer inventive step, because otherwise only new research processes could remain patentable, any finding based on known research processes would simply be obvious to try, whatever the efforts.”

This is similar to the 'Teffgate', where some arbitrary numbers were used to attribute “innovative” aspects to what’s in nature (and has been in nature since before humans even existed).

It was very much expected that Team UPC firms (like the above) would condemn or spin or just moan about this decision. Team UPC is a very dishonest bunch which only cares about litigation, not science. Wait and watch their next stunts. They lie a lot.

As an example of their lies, consider this UPC ‘book’ spin. It’s amazing and it’s only days old. The FFII’s President has already responded to it with: “The complaint is secret, on which basis they gonna discuss?” (the complaint)

“It was very much expected that Team UPC firms (like the above) would condemn or spin or just moan about this decision. Team UPC is a very dishonest bunch which only cares about litigation, not science.”Basically, the longtime UPC booster (going by the Twitter handle “UPCtracker”) wrote: “Oxford University press and CH Beck have published the legal commentary on the UPC (Tilmann/Plassmann ed.), an event which the German constitutional complainant saw as a bad omen or indicator his UPC complaint could be denied shortly. Case still pending, however.”

So we’re supposed to think, yet again, that there’s a decision coming soon (dismissal). How many times before have they lied along those lines? We’ve lost count. The tweet (reply) from the FFII’s President had us investigating the merit of the statement. It’s basically a lie.

In fact, the book in question, namely its German version, has still not been published. Its publisher, C. H. Beck, currently announce it for “approximately May 2019″ (see their German Web page). The book mentioned in the said tweet is the English version which is sold by a different publisher (Oxford University Press) and has been on the market since late summer of 2018 (see the same Web site but a different page). Although it has a higher price, it is commercially not as interesting as the German version which will sell in much higher numbers should the UPC become a reality. Either the said UPC advocate does not understand the difference between the two books, which we doubt, or he is acting against his better judgment, trying to spin a story suiting his own interests. Stay classy, Team UPC. Stay vigilant, FCC.

Share in other sites/networks: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Reddit
  • email

This post is also available in Gemini over at:

gemini://gemini.techrights.org/2019/03/30/uk-supreme-court-and-fcc/

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

What Else is New


  1. [Meme] Bundestagate Series Spoiler

    The chain of command/s at the EPO typically leads to major tragedy



  2. Breaking News: Campinos to Appear Before the Legals Affairs Committee of the European Parliament on Monday 12 April

    "Some MEPs have been briefed about ongoing governance deficits at the EPO, in particular the lack of GDPR compliance and the sell-out of "digital sovereignty" to Microsoft, but it remains to be seen whether or not they will dare to bring these issues up during the hearing."



  3. Pro-FSF Petition (“An Open Letter in Support of Richard Matthew Stallman Being Reinstated by the Free Software Foundation”) Tops 6,200 Signatures

    Monopolies and their media, along with their NGOs, have spoken and incited based on falsehoods; people now respond so the hate letter has a real crisis



  4. Links 10/4/2021: osbuild 28, KDE Frameworks 5.81.0

    Links for the day



  5. EPOLeaks on Misleading the Bundestag -- Part 12: A Worthy Successor to His Mentor?

    We examine the role of Christoph Ernst in EPO management, both in the Benoît Battistelli era and the António Campinos era (plenty to hide)



  6. USPTO for Monopolies, Keeping GNU/Linux in the Dark

    Growing evidence of gross discrimination against GNU/Linux (or Free software, even BSD/UNIX) users at the USPTO is too hard to ignore; some people out there challenge the Office over this travesty



  7. Accessibility and Availability First

    To make Techrights more widely accessible and more difficult to block/censor we've been making further changes, including self-hosting where possible



  8. Self-Hosting Videos With Free Formats and Animated Previews, Watermarks/Logos and Translucency

    We examine the power of video editing with ffmpeg, chained with command-line scripting and HTML5 features



  9. Links 10/4/2021: Linux on M1, Wine 6.6, ClamAV 0.103.2

    Links for the day



  10. Lunduke: On Mob Justice in the Tech Industry

    A new video from the former Microsofter who fears the phenomenon that’s adopted by companies like IBM



  11. IRC Proceedings: Friday, April 09, 2021

    IRC logs for Friday, April 09, 2021



  12. EPOLeaks on Misleading the Bundestag — Appendix (Benoît Battistelli's Vichy Syndrome): Georges Henri Léon Battistelli and Charles Robert Battistelli

    Local copies with evidence of or something concrete about Benoît Battistelli’s connection to unsavoury — and by today’s standards outright fascistic — politics



  13. IBM Doubles Down on Masters Being an Acceptable Word in the Context of Technology

    3 days after this post which disproves IBM's stance or shows its double standards it once again says “Masters” in its official blog (won’t that offend and alienate some people as they insist?)



  14. Hate Letter Against Richard Matthew Stallman (RMS) Backfired So Spectacularly That Signers Asked to Revoke Their Own Signatures and the List Was Then Frozen Permanently (Updated)

    "An open letter in support of Richard Matthew Stallman being reinstated by the Free Software Foundation" tops 6,100 signatures (graph generated just moments ago)



  15. EPOLeaks on Misleading the Bundestag -- Part 11: The BMJV's Tweedledee: Dr Christoph Ernst

    The right-hand man of António Campinos plays a role similar to that of Herr Lutz before him



  16. Links 9/4/2021: Tanglet 1.6.0 and HPVM 1.0

    Links for the day



  17. The Libel Against Richard Stallman Did Not Age Well

    Almost 2 years down the line libel about the founder of the FSF remains online, uncorrected (in sites funded by Microsoft and IBM)



  18. The Letter in Support of the FSF and Richard Stallman is Backed by the International Community, Not American Monopolies and Nationalistic Elements

    Free software is for everybody to use, internationally, it is not the asset of a bunch of current and old monopolists (connected to the US military) that also control the media; the nature of the signatures says that out loud



  19. Gemini Over IPFS (Decentralised Web, Accessed Over Gemini Protocol)

    The Gemini protocol (gemini://) can already be used to fetch (at the back end) and present objects from a P2P-like network; we're currently exploring practical use cases and possibilities



  20. News Sites That Talk About Patents Have Become Shameless Self-Promotion 'Plugs' by Law Firms (and Sometimes Outright 'Spam' for Litigation)

    The sources of news about patent affairs have dried up; sites that actually used to investigate and report facts have since then shut down or defected to the Public Relations/marketing industry



  21. Links 9/4/2021: Kubernetes 1.21 and FFmpeg 4.4 Released

    Links for the day



  22. IRC Proceedings: Thursday, April 08, 2021

    IRC logs for Thursday, April 08, 2021



  23. [Meme] Self-styled Judges

    To suit a recurring theme at the EPO we hereby present Roland Lutz, a self-styled judge



  24. EPOLeaks on Misleading the Bundestag -- Part 10: A Faithful Lapdog Despised and Reviled by EPO Staff

    "In any event, the "Nazi" jibes directed against Lutz seem to have triggered Battistelli who decided to take revenge on his perceived enemies inside the EPO by smearing them as “Nazis”."



  25. Links 8/4/2021: GnuPG 2.3.0, Xen 4.15, Xfdashboard 0.9.2

    Links for the day



  26. The Hate Letter Which Backfired

    The FSF is more closely aligned with its founder's vision, his antagonists have left or are leaving, and that old hate letter turned out to be a loud minority (made to appear louder by biased media) emboldened by a gish gallop of lies



  27. IRC Proceedings: Wednesday, April 07, 2021

    IRC logs for Wednesday, April 07, 2021



  28. IBM: We Can Say It... You Cannot

    Blog posts such as this new one help show the hypocrisy or the double standards of IBM, looking to control speech while attacking people's (software) freedom/civil liberties and profiting from atomic bombs



  29. The Collapse of Microsoft Windows

    Although the corporate media keeps insisting that Microsoft is doing well, government (or military) bailouts keep the company afloat while its desperate attempts to remain relevant (as the common carrier languishes) merit a debate



  30. Links 8/4/2021: Mesa 21.0.2, GNU Releases, and Stable Kernels

    Links for the day


RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

Recent Posts